‘Science Fiction Medicine’: Moderna Developing mRNA Injection to Treat Heart Failure

Michael Nevradakis

Moderna raked in signi cant earnings in 2022, based on $18.4 billion in sales of its mRNA COVID-19 vaccine — the company’s one and only product on the market.

But in a Jan. 9 update on the company’s “industry-leading mRNA pipeline,” Moderna told investors it is developing multiple new mRNA products — including a treatment designed to be injected directly into the hearts of patients who have sustained heart attacks or heart failure.

Moderna said it launched a phase 1B clinical trial of its mRNA-0184 injection, which it said: “encodes for relaxin, a naturally occurring hormone that is known to cause hemodynamic changes that are potentially bene cial for heart failure patients.”

Latest articles

Dawn Lester & David Parker … As we have shown in many...
Dawn Lester & David Parker Modern medicine is widely acclaimed as being...
Dawn Lester & David Parker In parts one and two, we showed...
Dawn Lester & David Parker In the three previous parts of this...
Roger Koops For those who may not recall Chicken Little (AKA Henny...
Tristan Coleman Does the latest ‘climate consensus’ study show a genuine agreement...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!